| Literature DB >> 30970839 |
T M S Udenni Gunathilake1, Yern Chee Ching2, Kuan Yong Ching3, Cheng Hock Chuah4, Luqman Chuah Abdullah5.
Abstract
Extensive employment of biomaterials in the areas of biomedical and microbiological applications is considered to be of prime importance. As expected, oil based polymer materials were gradually replaced by natural or synthetic biopolymers due to their well-known intrinsic characteristics such as biodegradability, non-toxicity and biocompatibility. Literature on this subject was found to be expanding, especially in the areas of biomedical and microbiological applications. Introduction of porosity into a biomaterial broadens the scope of applications. In addition, increased porosity can have a beneficial effect for the applications which exploit their exceptional ability of loading, retaining and releasing of fluids. Different applications require a unique set of pore characteristics in the biopolymer matrix. Various pore morphologies have different characteristics and contribute different performances to the biopolymer matrix. Fabrication methods for bio-based porous materials more related to the choice of material. By choosing the appropriate combination of fabrication technique and biomaterial employment, one can obtain tunable pore characteristic to fulfill the requirements of desired application. In our previous review, we described the literature related to biopolymers and fabrication techniques of porous materials. This paper we will focus on the biomedical and microbiological applications of bio-based porous materials.Entities:
Keywords: biocompatibility; biomaterial; porosity
Year: 2017 PMID: 30970839 PMCID: PMC6431923 DOI: 10.3390/polym9050160
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Schematic representation of tissue regeneration using porous bioscaffold.
Optimal pore size for cell infiltration reported by previous researchers [25,26,27,28,29,30].
| Cell types cultured | Optimal pore size (µm) | Reference |
|---|---|---|
| Hepatocytes | 20 µm | [ |
| Osteogenic cells | 100–150 µm | [ |
| Fibroblast | 5–15 µm | [ |
| Adult mammalian skin cells | 20–125 µm | [ |
| Smooth muscle cells | 60–150 µm | [ |
| Endothelial cells | <80 µm | [ |
Summary of pore characteristics of biopolymer scaffolds prepared from different fabrication methods for culturing different types of cells [32,35,36,37,38].
| Cell/tissue type | Biopolymer | Method of fabrication | Pore characteristics | Reference |
|---|---|---|---|---|
| Small-diameter blood vessels | Poly( | Thermally induced phase-separation | Porosity decreased from 95% to 90% with increasing the polymer concentration from 2.5% to 10%. Pore size decreased from 115–140 µm to 20–40 µm with decreasing the phase-separation temperature from −20 to −196 °C | [ |
| Hepatocytes | Chitosan | Lyophilization | Porosity of 90% and mean pore size between 50–200 µm | [ |
| Bone tissue | Hydroxyapatite and gelatin | Solvent-casting method combined with freeze drying | Open, interconnected porous structure with a pore size of 80–400 µm and porosity 70% | [ |
| Human dermal fibroblasts | Chitosan | Freeze drying | Pore size between 40–140 µm, and average porosity about 93% ± 12.57% | [ |
| Osteoblast | Poly(lactic- | Supercritical CO2 | Porosity of 88.9% and pore size of 205.7 µm | [ |
Figure 2Drug diffusion from the biopolymer matrix containing dispersed drug.
Pore characteristics of different drug delivery systems prepared from various fabrication method [43,44,45,46,48,49,50,51].
| Type of drug | Biopolymer | Method of fabrication | Pore characteristics | Reference |
|---|---|---|---|---|
| Doxycycline hyclate | Chitosan | Freeze drying | Well interconnected pores with diameter about 80–130 µm | [ |
| Ampicillin and cytochrome C | Poly(lactic acid) | Robotic dispensing technique and room temperature ionic liquid | Pore size of 2.43 µm and microporosity of ~70% | [ |
| Metoprolol succinate | Hydroxypropyl-methylcellulose and chitosan | Gas blowing | Pore size between 100–1000 µm and porosity of 47.11% ± 1.80% | [ |
| Amoxicillin trihydrate | Chitosan | Freeze drying | Pore sizes were obtained from100 to 500 µm with increasing the crosslinking agent from 1:0.068 to 1:0.30 (molar ratio-chitosan: crosslinker) | [ |
| Tetracycline hydrochloride | Hydroxyapatite/chitosan | Freeze drying | Pore diameter 45 ± 17 µm. | [ |
| Rosiglitazone maleate | Chitosan/poly(vinyl alcohol) | Gas foaming | Superporous hydrogel with capillary porous structures. Porosity increased from 38.3 ± 2.2 to 88.2 ± 2.1 with increasing the amount of glyoxal (crosslinker) | [ |
| Ranitidine | Carboxymethylcellulose hydrogel | Gas foaming | Porosity decreased from 69.30 ± 4.36 to 42.38 ± 2.68 with the addition of sodium carboxymethyl cellulose | [ |
| Curcumin | Nanocellulose reinforced chitosan hydrogel | Gas foaming | Highly interconnected pores with pore sizes >100 µm | [ |
Figure 3Releasing of antimicrobial agent from food contacting layer of multilayer packaging material.